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Abstract: Caspase-3, onto which there is a convergence of the intrinsic and extrinsic apoptotic
pathways, is the main executioner of apoptosis. We here review the current literature on the
intervention of the protease in the execution of naturally occurring neuronal death (NOND) during
cerebellar development. We will consider data on the most common altricial species (rat, mouse and
rabbit), as well as humans. Among the different types of neurons and glia in cerebellum, there is
ample evidence for an intervention of caspase-3 in the regulation of NOND of the post-mitotic
cerebellar granule cells (CGCs) and Purkinje neurons, as a consequence of failure to establish
proper synaptic contacts with target (secondary cell death). It seems possible that the GABAergic
interneurons also undergo a similar type of secondary cell death, but the intervention of caspase-3
in this case still remains to be clarified in full. Remarkably, CGCs also undergo primary cell death
at the precursor/pre-migratory stage of differentiation, in this instance without the intervention of
caspase-3. Glial cells, as well, undergo a process of regulated cell death, but it seems possible that
expression of caspase-3, at least in the Bergmann glia, is related to differentiation rather than death.
Keywords: caspase-3; cell death; apoptosis; cell proliferation; neurons; glia; cerebellum; development
1. Introduction
Caspase-3 is a key enzyme in the execution of apoptosis. The enzyme belongs to the caspase (from
cysteine-aspartate protease) family, one of the six families of proteases that have important functions
in normal neuronal development and neuropathology [1]. Caspases are endoproteases and mediate
some forms of neuronal programmed cell death (PCD), such as apoptosis and pyroptosis, which are
dependent on caspase-3 and caspase-1, respectively [2].
During neurodevelopment, a process of PCD occurs by which neurons that are produced
in excess are removed from tissue to sculpt the mature brain and spinal cord. PCD may
depend or not on the activation of caspases and thus can be didactically subdivided into
a caspase-dependent and -independent PCD. The former consists of caspase-3-dependent apoptosis
and caspase-1-dependent pyroptosis. Today there are no reports on the occurrence of pyroptosis
in cerebellum, whereas, as it will be discussed in this review, caspase-3 has long been known to be
involved into cerebellar PCD. Caspase-independent PCD consists of calpain-dependent autophagy
and receptor-interacting serine/threonine-protein kinases 1, 3 and mixed lineage kinase domain-like
pseudokinase (RIPK1-RIPK3-MLKL) -dependent necroptosis, a process which is limited by cathepsins
through cleavage of RIPK1 (see [1] for a very recent review). Although some forms of autophagic cell
death were observed during normal postnatal cerebellar development in normal mice [3] as well as
in Reeler and Lurcher mutants [3,4], it appeared that, at least in Lurcher, cell death was not caused by
autophagy but was rather a necrosis with autophagic features, both in vivo and in vitro [4]. In addition,
it was recently demonstrated that the administration of calpeptin, a potent, cell-permeable calpain
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inhibitor, promoted the apoptotic cell death of the cerebellar granule cells (CGCs) in postnatal rats [5],
and that mutations in the gene encoding for calpain-1 in several mammals, including humans, resulted
in alterations of cerebellar development, with increased apoptotic cell death of the CGCs and ataxia [6].
Therefore, it seems highly probable that calpain is protective against the apoptotic cell death of CGCs
during development, rather than being involved in the autophagy of these neurons.
To date, necroptosis has been described only in the cerebellum of Niemann-Pick type C1 (NPC1)
diseased mice and human patients, primarily affecting the Purkinje neurons (PNs) [7,8]. Therefore,
among the several types of PCD that occur during cerebellar development caspase 3-dependent
apoptosis is the most physiologically relevant along the process of naturally occurring (physiological)
neuronal death (NOND). In the past, we reviewed the cellular and molecular mechanisms of neuronal
apoptosis in the mammalian central nervous system (CNS) [9]. We subsequently demonstrated the
occurrence of two different cellular mechanisms of cerebellar NOND in rabbit [10] and mouse [11].
In the two species, we showed that apoptosis of proliferating precursors and young pre-migratory
cells occurred in the absence of caspase-3 cleavage, whereas the death of post-mitotic, post-migratory
neurons was directly linked to caspase-3 activation. We here provide an up-to-date picture of the
intervention of the protease in the normal course of mammalian cerebellar development. There are
certain discrepancies in the investigations that have, until now, been dedicated to this subject, and we
will try to highlight these from a correct and critical perspective.
Readers who are not familiar with the basic molecular and cellular mechanisms of neuronal cell
death would much benefit from referring to one of the numerous existing reviews on these subjects,
as we will only mention some relevant issues to put discussion under the right frame of reference here.
To be better cognizant of the significance (or, at times, insignificance) of the research that we have here
described, one should also, crucially, be aware of the technical drawbacks that are associated with
a proper identification of dead and proliferating cells, since, as we will discuss widely in the following
sections, during cerebellar development, the two processes are tightly interconnected.
2. The Recognition of Cell Death in Cerebellar Neurons
2.1. The Struggle for the Recognition of Cell Death of Neurons
It has been written that the tyranny over evidence is nowhere more glaringly apparent than
in the history of the delayed discovery of neuronal death during normal development [12]. At the
basis of such a “tyranny”, there was the theory that both ontogeny and phylogeny were progressive,
from lower and less organized nervous systems to higher and more organized brains. Evidence of
NOND was indeed provided as early as the 1880s [13,14], but it was not acknowledged, because it
conflicted with the widely accepted notion of progressive development. Therefore, reports of neuronal
death were interred in the scientific literature, to be unburied much later as queer archeological remains.
Today, these papers come back to obsess us, as they obsessed previous generations of neuroscientists,
who could not accept any knowledge that went against their treasured theories.
The long delay in believing the existence of developmental neuronal death has been regarded
as an historical enigma, as discussed in [12]. Deterministic theories of development made it hard to
conceive of the demolition of temporary structures as a part of the normal development, as it was not
easy to imagine, at that time, that construction and destruction could be proceeding simultaneously
during ontogeny.
The first descriptions of cell death in neurons were provided in fish and amphibians by
Beard [13,14], who, at the end of the nineteenth century, described the loss of a specific population
of mechanoreceptors in the spinal cord of these animals. A few years later, in 1906, Collin reported
the occurrence of dorsal root ganglion and motor neuron death during the embryonic development
of chicks [15]. After two decades, Ernst first realized that in several areas of the CNS and peripheral
nervous system, an overproduction of neurons was indeed followed by the death of a substantial
fraction of them [16]. He was also the first to propose a general theory of developmental neuron death,
Int. J. Mol. Sci. 2018, 19, 3999 3 of 23
to obtain supporting evidence for his theory, and to describe the existence of three main types of cell
death during normal neurodevelopment: the first, afterwards named phylogenetic by Glücksmann [17],
occurring during the regression of vestigial organs; the second, then referred to as morphogenetic,
during the morphological modifications of organ anlages; the third, subsequently called histogenetic,
during tissue remodeling.
Glücksmann’s 1951 review of cell death during normal development was indeed the first
publication to prime discussion on the importance of neuronal cell death in experimental limb
amputation [17], a widely diffused experimental paradigm in neuroembryology of the time. A few
years later, Hamburger was able to show that it was an increased cell death, and not a mitotic or
a differentiation failure, to be responsible for the decrease in the number of motorneurons in the chick
embryo after limb amputation [18]. Then, Hughes showed the occurrence of a large overproduction of
motorneurons during normal development in Xenopus and that the death of these cells was a critical
factor for the control of their final number [19,20], and Prestige demonstrated the same phenomenon
in tadpole dorsal root ganglion and spinal cord neurons [21].
Years later, in the 1970s, the idea that tissue assembly could take place by means of a selective
deletion of temporary structures started to gain more attention. Before that time, the dominant idea,
boosted by the cogent evidence in support of the neurotrophic theory, established after the original
work of Levi-Montalcini and Cohen [22], was that matching between the number of central neurons and
their peripheral targets was physiologically achieved by co-orchestrated programs of cell proliferation,
migration, and differentiation, but not death. This explains why works on developmental neuronal
death initially received very little attention. However, after these pioneering studies, the idea that
a form of PCD, already theorized conceptually, indeed occurred at different stages of development
and growth of the nervous system and that PCD was independent of external insults quickly began
to take hold. Eventually, PCD was recognized as a highly phylogenetically conserved physiological
mechanism by which eukaryotic cells die following a stereotyped series of molecular and cellular
events during the development and differentiation of all tissues and organs, including those of the
nervous system.
2.2. The Discovery of PCD and NOND in Cerebellum
In altricial mammals, i.e., mammals with inept offspring, a substantial fraction of cerebellar
development occurs postnatally, within a temporal window of about two-three weeks in rodents
and rabbits and up to three months in humans. At these stages, the cerebellar cortex is made of
four layers named, from the most superficial contacting the pia mater, the external granular layer
(EGL), the molecular layer, the Purkinje cells’ layer and the internal granular layer (IGL). The EGL
is temporary, and disappears upon completion of cerebellar differentiation. Thus, only three layers
remain in the mature cortex, where the IGL becomes the single granular layer to be recognized [23].
Acknowledgement of cerebellar NOND inside this temporal window had also to face the dogmatic
views of its time. Therefore, it was not surprising that the first report on the subject, dating
back to the end of the 1970s, concluded that death did not contribute significantly to cerebellar
development [24]. In those years, the initial studies on cerebellar cell death were focused onto the
alterations induced by thyroid dysfunction during postnatal development, rather than on normal
cerebellar neurogenesis [25,26]. One of these two studies considered, by the use of quantitative
autoradiography, the effects of experimental hypo- and hyperthyroidism on the rates of cell
proliferation and generation in the EGL of P10 rats, reporting that both conditions reduced the mitotic
rate [25], albeit with different mechanisms. Namely, hyperthyroidism was referred to shorten the cell
cycle by decreasing the duration of the G1 phase and it was hypothesized that thyroid over-functioning
promoted an early neuronal differentiation of the EGL precursors that stopped to proliferate and
acquired the typical features of maturity. On the other hand, hypothyroidism had no effect onto the
length of the cell cycle, but reduced the rate of cell acquisition in the absence of any significant change
in cell death [25]. Hypothyroidism was, instead, described to be responsible of an increased cell death
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in the IGL of two- to three-week postnatal rats, with a peak at P10 in the other mentioned study [26].
Notably, the authors reported that, at this stage of development, cell death was maximal also in normal
control animals. A few years later, in the early 1980s, signs of cell degeneration were described in
the form of pyknotic cells in normal P5, P10 and P12 hamster cerebella; these pyknotic nuclei were
by far more evident in the deep half of the IGL that, at all the three postnatal ages studied, showed
a greater cell loss than the superficial half [27]. A series of papers then followed, in which cell death
was described in several cerebellar mouse ataxic spontaneous mutants including Lurcher [28], Pcd [29],
Staggerer [30,31], Nervous [32] and Weaver [33].
In 1993, Wood and colleagues published a seminal paper demonstrating that cell death in the
postnatal mouse cerebellum was apoptotic [34]. To do so they used the terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) technique, an in situ DNA end labeling procedure for
detecting the double-strand DNA breaks typical of apoptosis [35]. The application of the TUNEL
method (and other in situ DNA labeling techniques) to the study of cell death, as well as the use
of different biochemical approaches to detect oligonucleosomal DNA fragments in tissue extracts
allowed demonstrating that cerebellar NOND was apoptotic in several mammals, including all the
most commonly used laboratory species and humans [36]. Qualitative (agarose gel electrophoresis
and TUNEL) and quantitative (ELISA for oligonucleosomal DNA fragments) estimates of apoptosis
demonstrated that the rat cerebellum displayed an initial intense apoptotic peak at P10 and a second
smaller peak at P21 [37]. The P10 peak was coincident with the timing of cell death reported in earlier
purely morphological studies on neurodegeneration that were mainly based onto the observation
of nuclear pyknosis. In parallel, apoptosis was reported to be the main form of cell death occurring
in Lurcher [38] and Weaver [39] mutants and to affect the cerebellar granule cells when the PNs were
ablated by, e.g., the specific expression of diphtheria toxin in transgenic mice [40]. At the same time,
another study used the TUNEL method and electron microscopy to confirm that the pyknotic cells in
the postnatal cerebellar cortex were indeed undergoing apoptosis and, very importantly, employed
immunocytochemistry to better characterize the nature of the dying cells in the white matter and IGL,
reaching the conclusion that 50–70% of the pyknotic cells were astrocytes [41].
3. Caspase-3 in Cerebellar Development
3.1. Modes of Cell Death in Neurons and Their Relevance to Cerebellar Development
It is now widely accepted that a substantial fraction of the neurons produced during neurogenesis
die before the full maturation of the nervous system, and that nearly all classes of neurons are produced
in excess during development. These oversized populations of neurons are then significantly reduced
during NOND, by a relatively limited number of widely investigated modalities that are not exclusive
to neurons but, in a more general context, affect all eukaryotic cells [42].
The importance of morphological observation for a correct identification of the mode of cell death
in neurons (and other cells) is rooted into the classic discrimination between apoptosis—the first
morphological form of PCD to be recognized (see below)—and necrosis, a term that was originally
employed by Virchow to indicate the death of cells in response to a pathological event [43]. After PCD
was acknowledged as a common phenomenon in development, an ultrastructural study on several
embryonic tissues proposed that there were three main types of cell death, on the basis of the role played
by lysosomes in cell disruption [44]. In the first type, death occurs in the absence of an activation of
the cell’s endogenous lysosomes. Nonetheless, cells are eventually disposed of by tissue macrophages’
phagocytosis and secondary lysosome activation. This process has also been more precisely referred
to as heterophagocytosis. In autophagocytosis, cells are instead removed from tissues after activation of
their own lysosomal enzymes, whereas in the third type of cell death, there is no obvious lysosome
intervention. The first two types are by far the more common and have been described by various
authors starting from the 1960s. The ultrastructural features of type 1 cell death in Schweichel and
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Merker classification [44] correspond to the current definition of apoptosis, while at least a variant of
type 3 shares several features with necrosis [45].
Today several other kinds of cell death have been recognized in neurons [46], each displaying
a typical cohort of structural and biomolecular changes, but with widespread occurrence of
intermediate features that make the entire array of the forms that cell death can assume a continuum
rather than constituting fully separate entities (Figure 1). Among the several configurations of cell
death that can occur in NOND, apoptosis is the one that, by a considerable margin, most directly
relates to the present discussion.
Apoptosis
Although often considered the prototype form of PCD—and often erroneously indicated as
PCD—apoptosis is only one of several types of NOND. Such a misinterpretation derived from the
initial recognition of apoptosis as the most widely diffused mode of neuronal cell death.
Apoptosis was originally defined as a distinct type of cell death according to a series of
characteristic ultrastructural features that depend on a stereotyped sequence of events starting
from nuclear and cytoplasmic condensation, and leading to cell fragmentation and, eventually,
phagocytosis [47]. Initially Kerr and co-authors [47] used the term shrinkage necrosis to describe
this form of cell death. Subsequently, they coined the word apoptosis (from the Greek = falling of the
leaves), which indicates the dropping of leaves from trees or petals from flowers, to emphasize its
occurrence in normal tissue turnover.
Apoptosis involves a chain of morphologically well-defined steps that can only in part be
appreciated by light microscopy, but are most clear at the transmission electron microscope (TEM)
level (Figure 1).
Nuclear changes are the first unequivocal sign of apoptosis: at the start, they consist in chromatin
condensation and segregation into very electron-dense, sharply delineated masses that abut the nuclear
envelope. High-magnification TEM images reveal that these masses of chromatin are made up of
closely packed, fine granular material. Initial condensation of the nucleus eventually leads to true
nuclear pyknosis. At the same time, cytoplasmic condensation also occurs, with an increase in the
density of the cytosol and the appearance of some vacuoles. The cell organelles retain a healthy
appearance but become closely packed, likely because of a remarkable cytosolic loss. Ribosomes get
separated from the rough endoplasmic reticulum and polysomes, to eventually disappear. As apoptosis
proceeds further, the cell and its nucleus become more irregular in shape: the nucleus buds to produce
discrete fragments, still surrounded by an intact envelope. The subsequent ultrastructural steps in
nuclear and chromatin condensation are paralleled by a well-characterized sequence of molecular
events. Eventually, the cell fragments into membrane-bounded apoptotic bodies that are cleared from
tissue by the resident microglia [48].
Apoptosis is accompanied by a specific pattern of DNA damage that leads to the formation of
low-molecular weight DNA oligomers. These can be visualized after DNA isolation and electrophoresis
in tissue extracts, or directly in situ by the use of the TUNEL technique [49]. The other main molecular
features of apoptosis are the release of cytochrome c from mitochondria, and the activation of caspases,
including caspase-3, in the cytosol [50,51]. It is well accepted that two major pathways can be
differentiated by considering the relative timing of caspase activation and mitochondrial release of
cytochrome c during apoptosis. In the first, which is exemplified by activation of death receptors,
an effector caspase is activated prior to mitochondrial alterations (extrinsic pathway). In the second,
cytochrome c is released from the mitochondrial intermembrane space prior to caspase activation
(intrinsic pathway). Notably, caspase-3 is the most important effector caspase upon which both pathways
converge. Molecules along the mitochondrial pathways comprise the proteins of the B-cell lymphoma
2 (BCL-2) family, which, in turn, is composed of pro- and anti-apoptotic members, the molecules of the
apoptosome, among which are caspase-9, the apoptotic peptidase activating factor 1 (Apaf1) and the
cytochrome c, and the family of the inhibitors of apoptosis proteins (IAPs).
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3.2. Intervention of Caspase-3 in Cerebellar Development
3.2.1. Basic Features of Cerebellar Development
During cerebellar development, well-orchestrated sequences of proliferative, differentiative,
migratory and death processes occur, and they affect the different populations of cerebellar neurons
and glia (Figure 2).
The cerebellar anlage displays two pri ary and two secondary proliferative zones (see [23] for
a recent review). The primary proliferative zones are the ventricular zone (VZ), i.e., the neuroepithelium
lining the walls of the fourth ventricle, and the rhombic lip (RL); the secondary proliferative zones
are the external germinal zone (EGZ) and the rostral germinal zone (RGZ). The VZ gives rise to all
GAB ergic cerebellar neurons, including the PNs and the interneurons [52,53]. The RL is part of the
neural fold of the dorsal edge of the fourth ventricle. Its upper part has long been known to generate
the glutamatergic cerebellar granule cells (CGCs) [54]. The CGC precursors are generated between
E15.5 to E17 in rat and mouse and migrate in an outward direction to originate the EGZ. During the
first postnatal weeks, the EGZ forms the EGL where the CGCs are ultimately generated. More recent
studies have demonstrated that, at earlier developmental stages (E9–E13.5 in mice), the EGZ also
generates the glutamatergic neurons of the cerebellar nuclei and the unipolar brush cells. The EGZ
additionally gives birth to part of the Golgi cells, at least in certain species. Finally, the RGZ has
a specific role in the development of the rostral cerebellum. After proliferation has ceased, post-mitotic
neurons migr e to their final destinations within the cerebellar cortex or the cerebellar nuclei. As we
will discuss below, cell death may hit the different subpopulations of cerebellar neurons at their pre- or
post-mitotic stages of differentiation. Death, for the most part, takes the form of apoptosis, and may or
not be strictly related to caspase-3 activation.
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layer; ML = molecular layer; P postnatal d y.
3.2.2. CGCs
CGCs are the most abundant neurons in the cerebellum and by far the most widely studied
cerebellar n urons in t context of cell death. The EGL wh re they are generated can be subdivided
further in o an outer and an inner por ion, respectively populated by highly proliferating precurso s
and non-proliferating, post-mitotic pre- igratory CGCs. As mentioned (see Section 3.2.1), the time
window in which the generation of these neurons occurs is strictly r lated to the degre of maturation of
the cerebellum at birth. In altricial mammals, the wind w spans from the first week aft birth to a few
w ks (r de ts, rabbits) or months (humans) th ncefo th. Soon after they are generat d, CGCs migrate
in a downward direction along the Bergm nn glia t reach the IGL, which will become their final
l cation, as the only granular layer in the mature cerebellar cortex. In parallel wit their maturation,
CGCs undergo impressive morphological changes and m ssive cell death. Thus, the generation of
CGCs relies on a controlled balance between clon l expansion and NOND. The two processes are
tightly interconnected in time and space, but still poorly understood with regard to their causative links.
Stud on these matters have been carr ed ut humans, as well as in several l boratory species.
3.2.2.1. Human Studies
In human fetuses, one of the first surveys on cerebellar development used classical histology and
proliferating cell nuclear antigen (PCNA) immunostaining to evaluate cell proliferation, and TUNEL
to label the nuclei with fragmented DNA and, hence, the occurrence of apoptosis. This study was
carried out between the 16th and the 24th week of gestation and reported that, on topographic
bases, there was not a mut al relationship betw en the two events [55]. In a later investigation,
wh re cell proliferation was examined between t 24th eek and the first postnatal year using Ki-67
immunostaining, it was observed that, i the EGL, proliferation mainly occurred between the 28th
a the 34th gestational week and persisted until the 8th postnatal month, whereas, in IGL, Ki-67
labeled cells ere detected only between th 24th a d the 36th week of gest tion [56]. In the same
paper, the occurren of very low percentages (0.3% at aximum) of degenerating pyknotic cells was
reported, as well. Afterwards, human cere ella fro the 17t week of gestation to one ye r postnatally
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were studied semi-quantitatively, again using PCNA immunostaining and TUNEL [57]. It was thus
shown that PCNA positive cells were present in all layers of the cerebellar cortex from the 17th to
the 25th prenatal week. In the EGL, proliferating cells persisted at high levels up to the 39th week,
declining thereafter and disappearing three months postnatally. TUNEL-positive cells were reported
within the EGL only, beginning from the 26th prenatal week and persisting up to one year after birth.
Notably, it was observed that these cells did not appear to suffer morphologically and were negative
for BCL-2 [57]. Another study on embryonic and fetal material (from the 8th to the 22nd week of
gestation) used the TUNEL method, as well as propidium iodide to stain the dead cells, and found
very high percentages of positive cells in the germinal zones of the cerebellar primordium, up to about
35% in the VZ and more than 30% in the EGZ, but only about 5% of the TUNEL-positive presumably
apoptotic cells were immunoreactive for the cell death receptor Fas (APO-1/CD95) [58]. This latter
observation suggested that the main contribution to NOND of the CGCs, which, as mentioned above,
are surely the most quantitatively relevant population of neurons originating from the EGZ, came from
activation of the intrinsic apoptotic pathway. In keeping with this possibility, in an earlier study
BCL-X, a member of the BCL-2 family of proteins, was reported to be highly expressed in the fetal
cerebellum [59].
Other observations on the relationship between proliferation and NOND in the postnatal period,
from birth to adulthood, were carried out in our laboratory by using Ki-67 immunostaining and the
TUNEL and T4 DNA ligase methods [36]. The latter was employed to confirm the true occurrence
of DNA fragmentation in the tissues under study, taking into consideration the problems that are
linked to the use of TUNEL on materials collected at necropsy, under non-flawless conditions of
tissue preservation. We thus observed that about one third of the cells in the EGL were Ki-67 positive
from birth to two months postnatally, with a subsequent decline of immunoreactivity up to the end
of the third month and a complete disappearance at P120. Apoptotic cells were 4–8% in the EGL,
less than 2% in the IGL and less than 3% in the white matter, from birth to the third postnatal month,
and thereafter disappeared. They were often immunoreactive for caspase-1, then known as human
interleukin-1β-converting enzyme [60] and caspase-3, which, at that time, was called 32-kDa putative
cysteine protease (CPP32) [61] (see [62] for additional information on nomenclature/classification of
caspases) but did not stain for BCL-2. Notably, 16.10% of the apoptotic cells (TUNEL-positive) were
immunoreactive for vimentin, a marker of the CGC precursors.
In summary, most of the studies on the development of the human cerebellum converged
to demonstrate that: (1) Proliferation of CGCs spans quite a long temporal window that roughly
encompasses the last two-thirds of gestation and ceases at the third–fourth postnatal month, in parallel
with the disappearance of the EGL; (2) NOND is restricted to two narrower temporal windows,
the first occurring during embryonic and fetal development (8–22 weeks) and the second during the
first three months after birth; (3) NOND is associated with DNA fragmentation and, thus, is very likely
of the apoptotic type and related to the activation of the intrinsic pathway; (4) Postnatal NOND is
primarily affecting the CGC precursors and may be associated with caspase-3 activation (see detection
of active caspase-3).
3.2.2.2. Animal Studies
Animal studies on the intervention of caspase-3 in the apoptotic processes affecting the CGCs are
substantially in line with the observations in humans. However, the possibility to experimentally label
the DNA-synthesizing (proliferating) cells with 3H-thymidine, BrdU or other thymidine analogues has
made it possible to better analyze the relationship between proliferation and NOND. Also, studies on
spontaneous mutants and transgenic models have much helped to clarify some of the main cellular
mechanisms that regulate NOND.
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Relationship of cell proliferation and NOND
Not surprisingly, the initial descriptions of proliferating or dying cells during cerebellar
development relied upon the observation of the cellular morphology with the detection of mitoses,
cytoplasm fragmentation or nuclear condensation, and pyknosis (for a recent review see [23]). Animal
studies have been focused on the postnatal period, as the most commonly used laboratory species
(rat, mouse, rabbit) are altricial.
Rats
In rats, the adult granular layer is fully mature around P50 [23]. In these studies, both the mitotic
index and the percentage of degenerating cells, mainly calculated in the EGL, were quite low (less
than 3%) [23]. As mentioned, administration of 3H-thymidine to label the DNA-synthesizing cells
was pivotal to a better comprehension of the relationship between cell proliferation and NOND
of the CGCs. Thus, a study on undernourished P9 rats, where cell death was detected on purely
morphological grounds, concluded, on a purely speculative basis, that commitment to death occurred
during the S-phase of the cell cycle [63]. Again on partly speculative grounds, after DNA-labeling with
14C-thymidine administered to P7–16 rats, death was estimated to affect less than 5% of the whole
population of newly generated cells [24]. Subsequent studies, for the most, used the TUNEL method to
label the apoptotic cells in the P3–16 cerebellum of normal rats [64], rats with hypothyroidism [65] or
lacking the endothelin receptor B [66] and, in some instances, to correlate death with cell proliferation.
In one of these studies, 54% of apoptotic EGL cells were reported to express PCNA, whereas only
slightly more than 22% and 15% of apoptotic neurons were located, respectively, in the post-mitotic and
pre-migratory zones of the EGL [64]. The authors thus concluded that, in EGL, dividing CGCs undergo
apoptosis more frequently than post-mitotic CGCs and hypothesized the existence of developmental
stage-specific mechanisms of apoptosis of these neurons. Observations on the mutant Flathead (Fh)
rat, confirmed the close link between apoptosis and proliferation during CGCs differentiation and
maturation. Fh rats display a flattened cranium, resting tremor, ataxia, progressive paralysis of the hind
limbs, and die between P21–P28. Homozygous rats have a dramatically reduced brain size caused by
a sudden and violent onset of apoptosis at E16, with a peak at E18. Late-developing structures such as
the cerebellar IGL become severely depleted of cells, in parallel with the appearance of multinucleated
cells in the EGL. These observations thus suggested that the aberrant cell death in Fh was due to
a defective cytokinesis in progenitor cells [67].
Further corroboration on the close link between cell proliferation and death of the CGCs came
from Western blot studies on the cerebellum of hyperbilirubinemic Gunn rats [68]. These animals
exhibited an increased cell cycle arrest in the late G0/G1 phase, characterized by a decrease in the
expression of cyclins A and A1 and cyclin-dependent kinase 2, which are active during the S phase
and peak at the S-G2 transition, and cyclin D1, which governs the transition from G1 to the S phase and
counteracts apoptosis. In parallel, the Gunn rats displayed marked increases of cyclin E, which also
regulates the G1-S transition but amplifies the apoptotic pathway, active caspase-3 and cleaved poly
ADP-ribose polymerase-1 (PARP-1), one of the main substrates of caspase-3.
Mice
In an early study comparing the development of the P0-P9 cerebellum in normal and weaver mice,
mitotic figures and pyknotic cells in the EGL were always very few in normal animals (2% and less than
0.5%, respectively), mainly located in the pre-migratory half of the EGL and, in Weaver, were quickly
cleared from tissue in four-seven hours [33]. Later, using the TUNEL method and/or after direct
TEM observation, several reports have been published that converged to demonstrate the presence of
variable amounts of apoptotic CGCs in the P0–10 EGL of normal mice [11,69] and mutants such as
Lurcher [70], Reeler [3,71], and Weaver [70]. However, few investigations were devoted to analyzing the
relationship of CGC proliferation and NOND in this species. In one of these studies, which employed
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BrdU and TUNEL labeling, active caspase-3 immunostaining and transmission electron microscopy,
a quite convincing demonstration was provided that the EGL neurons died through a process of PCD
soon after they exit from the cell cycle [72].
The relationship between proliferation and apoptosis is so strict that, in several circumstances,
it has been hypothesized that apoptosis was initiated by a re-enter into the cell cycle. This is the
case, e.g., of the Harlequin (Hq) mutant mice. The Hq mutation is a proviral insertion in the
apoptosis-inducing factor gene (aif ) that gives rise to a reduction of about 80% in Aif expression.
Hq mice display a progressive degeneration of terminally differentiated cerebellar neurons that is the
consequence of an exaggerated response to oxidative stress [73]. When aif was deleted at a very early
stage of development using an engrailed-1 (En1) promoter-driven cre recombinase gene, a dramatic
reduction in the population of CGC precursors was observed, as their proliferation was blocked before
initiation of the S phase [74]. Further analysis revealed that if aif was deleted later in embryogenesis,
using this time a nestin promoter-driven cre recombinase gene, CGCs survive for a longer period,
but are still unable to enter the S phase [74].
We have, more recently, studied cell proliferation and NOND in the normal and Reeler mouse
after BrdU administration and TUNEL labeling in the P0-25 interval [71]. When the density of
the BrdU-positive cells in EGL was correlated with the developmental stage, the correlation curve
in normal mice showed a maximum at P9 and a minimum at P25, whereas in the IGL there was
a maximum at P0 followed by negligible oscillations between P15–25. Correlation curves between the
numbers of apoptotic cells and the developmental stage were also calculated. In the EGL, the curve
was oscillatory, with a vertical positive asymptote immediately before birth, maxima at P9.5 and P23
(this latter, however, being quite low), and minima at P3 and P19.5. In the IGL, instead, the curve
was bell-shaped, starting with a vertical negative asymptote immediately after birth and a single
maximum at P4.5. It is noteworthy that in the EGL, there was a temporal coincidence, around P9, of the
proliferative and apoptotic peaks. This is fully in line with the results that we obtained previously
in rabbits using a totally different approach, which demonstrated a very tight temporal connection
(1–1.5 days) between the generation and death of precursors/pre-migratory CGCs (see Rabbits).
Remarkably, Reeler mice displayed statistically significant differences in the extent of cell proliferation
and apoptosis, as well as a derangement in their temporal trends along the timespan considered in
our study. In mutants, we also employed predictive statistics to show that proliferation, rather than
apoptosis, was the most important factor to determine the cellularity of the cerebellar cortex.
Rabbits
We analyzed the relationship of cell proliferation and death in the P0–30 rabbit cerebellum
after time-window labeling of proliferating cells in vivo to study the cell cycle kinetics; we also
used a variety of approaches to detect apoptosis, among which were histology and TEM analysis,
immunocytochemistry, TUNEL, genomic DNA electrophoresis, Western and Southern blotting [48].
We concentrated our analysis at P5, where, in Southern blots, DNA fragmentation was maximal, as was
cleavage of PARP-1 [75] in Western blots. We showed that CGCs and their precursors in the EGL
went through apoptosis within 24–36 h after their generation, to be thereafter cleared from tissue by
the resident microglia, an intervention that was also recently confirmed in rats [76]. After Southern
blotting and immunostaining, BrdU, the first thymidine analogue administered to rabbits in the time
window-procedure, was present at the level of low-size DNA oligomers as soon as twelve hours
after cell division. Therefore, this apoptotic phase was intrinsic to the EGL neurons and independent
of their synaptic interactions with targets. Apoptotic CGCs, although fewer in number, could also
be detected in the IGL; considering the results of cell cycle kinetics measurements and the rapid
tissue clearance by glia, we excluded that these neurons underwent DNA fragmentation in the
EGL to subsequently migrate to their final destination, but rather postulated that post-migratory
CGCs endured NOND as a failure to establish their synapses with the PNs. In a subsequent paper,
we established that pre-migratory CGCs in the EGL underwent apoptosis upon phosphorylation
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of checkpoint kinase 1 and hyper-phosphorylation of the retinoblastoma protein, suggesting that
NOND of pre-migratory CGCs was linked to activation of DNA checkpoint and alteration of the
normal cell cycle parameters [10]. In parallel, we also demonstrated that apoptosis of post-migratory
CGCs in the IGL was, instead, caspase-dependent (see below). Therefore, our observations in rabbits
were fully consistent with earlier studies on postnatal Lurcher mouse mutants and wild-type/Lurcher
chimeras where, after 3H-thymidine labeling of DNA-synthesizing (proliferating) cells and quantitative
estimations of the CGC population and size of their synaptic target, the existence of two distinct
mechanisms for developmental NOND of the CGCs were postulated [77].
Detection of active caspase-3
Assessment of the role of caspase-3 during CGC development in vivo was difficult for several
reasons, among which were the availability of good antibodies that specifically recognized the cleaved
(active) form of the enzyme, the very quick removal of the apoptotic cells from tissue, and the recently
demonstrated constitutive activity of the enzyme, at least in cerebellar slices [78].
As caspase-3 is ubiquitous, the first issue is of paramount importance, and it is very critical that
immunocytochemical localizations are accompanied by Western blots to assess the specificity of the
primary antibodies for the cleaved fragment of caspase-3 and to establish its presence in tissue extracts.
The inactive full-length caspase-3 is localized in the cytosol where it is cleaved by upstream caspases
along the intrinsic pathway; then the cleaved active enzyme rapidly translocates into the nucleus of
the cells undergoing PCD. As we have discussed in a previous review [9], it is notable that numerous
studies reported no immunostaining for the inactive zymogen, whereas it appeared that the expression
of the caspase-3 mRNA was highly regulated in parallel with the occurrence of postnatal apoptosis.
CNS alterations in caspase-3-deficient mice reflected the failure of NOND during neurogenesis. In the
cerebellum, but also in several other areas of CNS, these alterations, which were associated with
premature lethality, consisted of a diffuse hyperplasia, presence of ectopic cell masses, abnormal
structural organization and neuronal hypercellularity. Specifically, the decrease or suppression of cell
death in these mice has been linked with a block of the mitochondrial apoptotic pathway.
Although caspase-3 immunoreactive cells were observed in all the species considered in the section
Relationship of cell proliferation and NOND, their numbers were, in general, very low. For example,
only 28% of the TUNEL-positive neurons in the postnatal human cerebellum were immunoreactive for
caspase-3, so that these double-labeled cells represented about 1.1–2.2% of the EGL cells and only 0.5%
of those in IGL [36]. Similarly, in non-quantitative studies, only rare active caspase-3 immunoreactive
cells were reported in the rat [79], mouse [11,80] or rabbit [10] postnatal EGL or IGL, whereas another
study recorded a maximum of 5.9% immunoreactive cells in EGL at P8 and 2.4% in the IGL at P9 in
mice [81]. Although active caspase-3/TUNEL double-stained CGCs were observed in humans [36]
and the expression of active caspase-3 was associated with positive immunostaining of IGL neurons
for active caspase-7 and -9 in rabbits [10], studies in rat were controversial. An early study (which
was however carried out in organotypic cerebellar slices) showed that the EGL neurons underwent
apoptosis when they expressed PCNA, but not TAG-1, a marker protein of the post-mitotic and
pre-migratory CGCs [82]. They were thus interpreted to be precursors/pre-migratory CGCs, and their
apoptotic death was blocked by a caspase-1 inhibitor. In keeping with these ex vivo observations,
it was later demonstrated that the genetic ablation of caspase-3 in transgenic mice completely inhibited
NOND in EGL neurons [72]. However, another paper, instead, supported a non-apoptotic role for
active caspase-3 in the EGL cells and suggested a possible involvement of the enzyme in proliferation
and differentiation rather than in NOND [79]—see also Section 4. Non-Apoptotic Role of Caspase-3.
As mentioned, the immunocytochemical localization of active caspase-3 is associated with a series
of potential drawbacks. To overcome these obstacles, we employed alternative approaches, based
on the transfection of postnatal cerebellar slices with probes that enabled to monitor the activity of
the enzyme in live CGCs. Initially, we used the ApoAlert™ pcaspase3-sensor vector to analyze the
cleavage of caspase-3 during NOND [11]. This approach relied on the possibility of observing the
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nuclear translocation of a fluorescently tagged cytoplasmic reporter molecule after cleavage by the
protease in the transfected cells. It was thus possible to confirm the existence of caspase-3 dependent
and independent apoptotic phenomena affecting the CGCs at different stages of their maturation and
differentiation. However, such an approach was not amenable to quantitative studies, and thus was
of limited value for further pharmacological characterization. To overcome this important limitation,
more recently we used a caspase-3-sensitive fluorescence resonance energy transfer (FRET) probe
(pSCAT3-DEVD), which enabled us to image the active caspase ex vivo and to analyze its localization
and cellular dynamics in CGCs [78]. We thus measured the ratio of the emissions of the donor/acceptor
FRET pair (enhanced cyan fluorescent protein (ECFP)em/Venusem) in alive or fixed slices of the P5
mouse cerebellum. The specificity of the probe was confirmed with RNA interference and after
inhibition of the protease with Ac-DEVD-CMK. It was thus possible to demonstrate that caspase-3 was
constitutively active in CGCs and to identify the specific cellular compartment(s) of enzyme activation.
In addition, we could follow the fluctuations of the ECFPem/Venusem ratio along time, and its response
to 25 mM KCl-induced depolarization, or to increased intracellular Ca2+ after N-methyl-D-aspartate
(NMDA −1 mM), kainic acid (1 mM), or A23187 (100–200 µM).
The observation that, in postnatal CGCs, the activity of caspase-3 was dynamically regulated
and did not follow an on-off switch is important because, methodologically, it highlights the necessity
of a quantitative analysis of the levels of activation of the enzyme and of a critical reappraisal of the
histological observations simply made by the use of antibodies against cleaved caspase-3. In addition,
and in a more biologically relevant context, it gives support to the idea that there may be numerous
different opposing pathways directly or indirectly converging onto caspase-3 to regulate NOND
in CGCs. One of these mechanisms, which appeared to be specific for CGCs, e.g., involved the
immunoglobulin superfamily adhesion molecule close homolog of L1 (CHL1) that plays important
roles during the development of the nervous system. Recent work has, in fact, demonstrated that the
in vivo ablation of CHL1 during the second postnatal week of mouse cerebellar development caused
an enhanced death of CGCs, but not of the PNs [83]. Remarkably, immunostaining for active caspase-3
in CHL1-deficient mice increased in the IGL, but not the EGL, confirming the occurrence of a caspase-3
dependent cell death only in the former.
Molecular pathways and regulation of NOND in CGCs
The cellular and molecular mechanisms of NOND in the CGCs that meet onto the effector
caspase-3 have been widely investigated. As expected, many molecules that intervene in the intrinsic
and extrinsic apoptotic pathways in other neurons and/or non-neural cells have been localized in CGCs
and directly implicated in the regulation of death in these neurons. Along the intrinsic pathway there
is, however, a remarkable exception as Bax, one of the molecules of the Bcl-2 family of proteins, did not
appear to be involved in the process. However, it is widely accepted today that both Bax and Bak (and
in some cases, Bok) work together to induce intrinsic apoptosis, as demonstrated from observations
on bax−/−-bak−/− double knockout mice that display an anomalous cell accumulation in the CNS (see
Table 3 in [9] for references to the original studies on transgenic mice with a neuronal death/survival
phenotype). Therefore, one cannot exclude that the observations discussed below may somewhat have
underestimated the intervention of Bax in the CGC apoptosis. In adult bax−/− mice, which display
a numerical reduction of the PNs (see Section 3.2.3, below), the number of CGCs was unaffected,
indicating that Bax was not involved in NOND of the precursors/pre-migratory CGCs [84,85].
However, Bax seemed to regulate the post-mitotic, post-migratory CGC target-related secondary
death, as more CGCs survived in bax−/−:Lurcher double mutants (chimeras)—where the CGC target
is reduced as a consequence of the primary death of the PNs—than in control Lurcher mutants [84].
These observations gave further support to the notion that CGCs suffer two differently regulated
types of PCD, primary and secondary, which are, respectively, target independent or dependent.
Backing to this concept also came from investigations in vitro. In this experimental context, treatment
of the rat CGCs with the phosphatase inhibitor, okadaic acid (OKA) or the excitatory neurotransmitter
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L-glutamate resulted in an apoptotic progressive death [86]. However, the OKA-induced neurotoxicity
was accompanied by the activation of caspase-3, with the appearance of the typical oligonucleosomal
DNA ladder in Southern blots, whereas L-glutamate-induced neurotoxicity was not accompanied
by the activation of caspase-3 and other upstream caspases, or DNA laddering. Notably, both OKA
and L-glutamate induced a similar pattern of nuclear DNA disintegration into high-molecular weight
fragments. In addition, Z-DEVD-FMK, a specific caspase-3 inhibitor, and Z-VAD-FMK, a general
caspase inhibitor, inhibited both the oligonucleosomal and high-molecular weight DNA fragmentation
after OKA, but the two inhibitors were inefficacious to prevent the formation of high-molecular weight
DNA fragments after L-glutamate. Based on these results, it was concluded that the formation of
the high-molecular weight DNA fragments in CGCs accompanied both the caspase-dependent and
-independent types of cell death, further reinforcing the concept that multiple mechanisms in the
regulation of the excision of DNA loop domains occur during the death of these neurons.
Caspase-dependent PCD of the CGCs may not only follow the activation of the mitochondrial
pathways, as at least some of the molecules along the death receptor pathway have also been implicated
in the death of CGCs. One of these molecules is the Fas ligand (FasL), which displayed a pro-apoptotic
activity, eventually leading to a reduction in thickness of the IGL, and induced a marked increase of
caspase-3 activity in colorimetric assays and of immunoreactive CGCs in the IGL, bur not EGL [87].
The intervention of Fas in triggering certain forms of CGC apoptosis was also confirmed by more recent
in vitro and slice studies where the anti-apoptotic protein lifeguard (LFG), an inhibitor of the death
receptor pathway, was demonstrated to promote the survival of CGCs by interfering with caspase-8
activation and thence downstream caspases [88].
That both the intrinsic and extrinsic apoptotic pathways are activated in CGCs in response to
different apoptotic stimuli and/or their degree of differentiation was also supported by several studies
on some molecules of the IAP family, a group of structurally related proteins that are negative regulators
of the activity of caspases and comprises, among others survivin, XIAP and cIAPs [89]. In cancer
cells, survivin may be recruited to mitochondria and thence released back in the cytosol in response
to cell death stimuli. Survivin released from the mitochondria then forms a complex with XIAP that
thus becomes more stable and protects cells against proteasomal degradation, eventually leading to
a synergistic inhibition of effector and initiator caspases [89]. Studies in vitro into non-neuronal cells
long ago showed that survivin was capable of inhibiting caspase activity, so that apoptosis induced by
Fas or Bax and executed by caspase-3 was blocked [90]. In parallel, in addition to caspase inhibition,
several other functions have been ascribed to survivin, which is now unanimously recognized as
an indispensable regulator of cell division and to handle the balance between cell proliferation and
death [91]. Studies in which the Cre-loxP-system was used to generate mice lacking survivin in
neuronal precursor cells [92] then demonstrated that newborn conditional mutants displayed a marked
reduction in the size of the brain, associated with severe, multifocal apoptosis of many areas of CNS,
among which the cerebellum. In the latter, caspase-3 and caspase-9 activities were significantly
elevated, whereas, remarkably, bax expression was unchanged from controls. More recent observations
of cultured CGCs and histological sections have localized survivin, XIAP, cIAP-1 and cIAP-2 during
the course of postnatal maturation of rat cerebellum and detected an interaction between XIAP and
active caspase-3 [93,94]. Even more recently, we used postnatal mouse cerebellar slices to study the
functional interactions of caspase-3 and survivin in the process of NOND and experimental cell death
of CGCs [78]. We thus demonstrated that survivin reduced the basal levels of caspase-3 activation
in a series of double transfection experiments with the pSCAT3-DEVD caspase-3 sensor probe and
a second probe, pHcRed1-C1-survivin, driving the overexpression of the protein in CGCs under the
control of the HCVM promoter.
Along the two main pathways of apoptosis, among the molecules that were shown to modulate
postnatal CGC survival in vivo, there is L-glutamate, as the activation or inhibition of some of
its receptors, i.e., the metabotropic glutamate receptor 5 (mGluR5) [95] or the ionotropic NMDA
receptor [96], resulted in an increase or a decrease of the apoptotic cell death of the CGCs in the
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EGL and/or IGL. Specifically, it was observed that glutamate acted on mGluR5 as a functional
switch to regulate CGC survival in the EGL. Therefore, when the receptor is antagonized, NOND is
reduced, and vice versa, thereby controlling the final number of CGCs in the mature cerebellum [95].
On the contrary, when NMDA receptors were blocked, particularly in IGL, increased levels of DNA
fragmentation (both in Southern blots and after TUNEL) and caspase-3 (and caspase-1 at lower extent)
were observed, in parallel with a decrease of ornithine decarboxylase, a marker of CGC normal
differentiation [96].
Other molecules of interest are the high-affinity tropomyosin receptor kinase B (trkB) neurotrophin
receptor and the low-affinity p75 neurotrophin receptor (p75NTR). The brain-derived neurotrophic
factor (BDNF) is produced by the CGCs residing in the outer proliferative part of the EGL [9] and
positively regulates the survival and migration of these neurons by binding the trkB receptors that
are also expressed in EGL, very likely in an autocrine fashion, and IGL [97]. The BDNF precursor
molecule (proBDNF) is, instead, pro-apoptotic. Remarkably, in the rat cerebellum between E20 and P8,
the levels of the mature neurotrophin, as well as the BDNF/proBDNF ratio, negatively correlated with
the expression of active caspase-3 [98].
The functions of p75NTR have long been elusive, as they depend on the cell context and binding
to different co-receptors to activate specific intracellular pathways. Although the positive modulation
of apoptosis after brain injury is the best characterized function of p75NTR [99], in the recent past it was
shown that the receptor regulates the proper cell cycle exit of the CGC progenitors in the developing
rat and mouse EGL, an action prompted after binding with pro-neurotrophin 3, as, in the absence
of p75NTR, progenitors continue to proliferate beyond their normal period [100]. Even more recently,
it was observed that ablation of p75NTR did not directly affect NOND in mouse CGCs [101]. However,
the deletion of the downstream effector receptor interacting protein 2 (RIP2) increased CGC apoptosis.
Remarkably, CGC’s NOND was restored to basal levels when p75NTR was deleted in RIP2-deficient
mice indicating RIP2 as a crucial molecule for normal p75NTR signaling in these neurons.
3.2.2.9. Summary of Current Knowledge
In brief, current knowledge of the occurrence and regulation of NOND in CGCs of altricial species
can be summarized as follows: (1) In all species studied so far, including humans, there are two
postnatal apoptotic waves of NOND, in temporal sequence. The first wave hits the precursors and
pre-migratory CGCs in outer EGL (primary apoptosis), while the second affects the mature CGCs
during their migration to the IGL (secondary apoptosis). These two waves are preceded by a phase of
late embryonic apoptotic cell death that has been more extensively investigated in humans; (2) Primary
apoptosis may be tightly linked to cell cycle dysregulation, is independent from connection with
synaptic targets and very likely may be completed without the intervention of caspase-3, although this
issue might be worthy of further investigation, as the protease is constitutively and dynamically active
in CGCs. If so, Aif can be the effector molecule to trigger apoptosis in the absence of caspase-3 activation.
(3) Secondary apoptosis follows a failure to connect to the PN dendritic tree, the main synaptic target of
the mature CGC axons, i.e., the parallel fibers; and is tightly associated with the activation of caspase-3;
(4) Both primary and secondary apoptotic death of CGCs may be activated following the intrinsic or
extrinsic apoptotic pathways and differentially regulated by several biologically relevant molecules.
Obviously, molecules that are part of these pathways, such as survivin, play important roles in the
regulation of CGCs’ NOND, with the remarkable exception of Bax. Important regulators are also the
excitatory transmitter L-glutamate and BDNF with their related receptors.
3.2.3. PNs
In mouse, the PNs are generated between E10–E13 in the VZ [102]. They then migrate in
an outward direction along the radial glia to form a plate of immature cells in the intermediate
part of the cerebellar anlage. During subsequent maturation, the plate, which was originally composed
of several layers of cells, becomes a monolayer of well aligned cells, a process that is completed
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within the first week after birth in rat and mouse and governed by Reelin, a glycoprotein of the
extracellular matrix [103] produced by CGCs [104]. NOND affects the PNs in the course of their
generation and migration with a plateau during the first postnatal week and is important for late
compartmentation and wiring of the cerebellar cortex [105–108]. On ultrastructural bases, NOND
was apoptotic [3], depended upon caspase-3 activation as, e.g., 5.9% neurons in the Purkinje cell layer
were immunostained using an antibody that recognized the cleaved form of the enzyme at P3 [81],
and affected a higher number of PNs at P4 than P7 [109]. However, after combined 3H-thymidine
autoradiography, TUNEL and active caspase-3 immunostaining it was clear that the PCD of the
PNs was independent from their birth-date, i.e., it was not related to interactions with targets [109].
Immunocytochemical studies on the expression of the apoptosis-regulatory proteins Bid, Bcl-2, Bcl-XL,
Bax and Bak during development of murine nervous system were supportive about the apoptotic
nature of postnatal NOND of the PNs, as these neurons expressed high levels of Bid (pro-apoptotic)
and Bcl-XL (anti-apoptotic) at P7 [110]. Studies in humans are rare and limited to the embryonic period.
Human PNs started being recognizable around the 12th week of gestation and became organized into
a monolayer between the 16th and 28th week [111]. Initial observations on histopathological samples
from 12–24 weeks of gestation [55] or 17 weeks of gestation to 12 months postnatal [57] did not report
staining for PN apoptotic cells after TUNEL. However, in a subsequent investigation at 15–22 weeks
of gestation, about 4% of the cells in the Purkinje cell layer were reported to be TUNEL-positive and
about 5% immunoreactive for Fas, one of the main death receptors leading to PCD [58].
Much of our current knowledge of NOND of the PNs comes from studies on normal rodents
to which one has to add several ataxic spontaneous mutants, see, e.g., Table 2 in [3] and [112],
and numerous strains of transgenic mice. Among mouse mutants, PNs’ apoptosis has been
demonstrated in Reeler [3,71], Lurcher [113,114], Pcd [115] and Toppler [116] mice, whereas in Hotfoot
(and after experimental deletion of the ionotropic glutamate receptor delta 2—GluRδ2) delayed PN
cell death, and reductions in the extension of the PN dendritic tree were observed [117].
Broadly speaking, studies on NOND in PNs from transgenic mice have: (1) helped to confirm
its apoptotic nature; (2) elucidated some of the molecular and cellular mechanisms governing the
process; and (3) shed some light on its biological role. Under these perspectives, many observations
(discussed below) first converged to demonstrate the activation of the intrinsic mitochondrial apoptotic
pathways during PNs’ NOND. Notably, when one of the better-characterized pro-apoptotic genes
of the bcl-2 family, bax, was deleted, there was a drastic reduction in the number of TUNEL-positive
cells in the marginal zone of the cerebellar anlage. Remarkably, this is the zone where, during
embryonic development, the immature PNs are found along their route of outward migration to
the final position in the cerebellar cortex [118]. Therefore, it was not surprising that a misplacement
of these neurons followed postnatally [85]. After TUNEL and activated caspase-3 immunostaining,
the extent of NOND was drastically reduced in the Purkinje cell layer of the cerebellar cortex also
in the P5 cerebellum of bax-KO mice [118]. Data on the intervention of Bcl-2 onto PNs’ NOND are
more difficult to organize into a coherent frame. Not surprisingly, the number of PNs increased by
over 30% in one line of Bcl-2 overexpressing transgenics [84]. However, when transgenic mice were
generated in which the expression of human BCL-2, one of the most important negative regulator of
apoptosis, or the anti-apoptotic adenovirus E1B 19k was targeted to the PNs by specific regulatory
elements from the pcp2 gene some puzzling results were obtained in another study. In this survey,
amazingly, no significant numerical differences in the strongest BCL-2 expressing line were observed
compared to wild-type mice, and only a 14.2% increase was noted in the pcp2/E1B 19k transgenic
line [119]. Interestingly, the overexpression of bcl-2 or the deletion of bax in heterozygous Lurcher mice
only delayed the autonomous death of the PNs, which are known to undergo apoptosis as a direct
consequence of the gain of function mutation of the GluRδ2 [84]. Aif appears to be another important
regulator of the generation of the PNs [74]. It was in fact demonstrated that, when the encoding gene
was deleted at a very early stage of cerebellar development, there was a dramatic reduction in the
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number of the PNs. Such a reduction was consequent to premature entrance in the S-phase of the cell
cycle of the PN precursors, most of which failed to undergo mitosis to eventually die by apoptosis.
More recent observations also implicated the extrinsic death receptor apoptotic pathways in PN
NOND. Thus, LFG was shown to be highly expressed during early differentiation of cerebellum and to
affect cerebellar size, PN development, and IGL thickness [88]. In adult mice, LFG additionally
promoted PN maintenance. This was demonstrated by observing the onset of morphological
alterations and reduction in the density of the PNs, as well as increased active caspase-3 and
caspase-8 immunostaining in knockout mice or mice where the expression of LFG was reduced
by RNA silencing [88]. In these animals, LFG inhibited Fas-mediated cell death by interfering with
caspase-8 activation; such a mechanism was supported by the detection of higher numbers of active
caspase-8-positive PNs in adult mice lacking LFG.
Understanding the biological relevance of PNs’ NOND during cerebellar development is made
difficult also considering the mutual supportive function with the CGCs. Nonetheless, it is relevant
mentioning here that, when NOND was blocked, an enhanced PN survival compromised the normal
cerebellar function, as demonstrated after behavioral experiments [119]. It has also been documented
that, during normal cerebellar development, the PNs undergoing apoptotic NOND in the vermis were
highly localized at the level of the midline and in a lobule specific, parasagittal pattern so that PCD and
PCD-free zones could be easily observed and quantified, an observation considered to be important for
cerebellar histogenesis [108]. Finally, the misplacement of PNs that occurred when bax was knocked
out also led to the hypothesis that the removal of ectopically located PNs may be an important function
of developmental PCD [85].
3.2.4. GABAergic Interneurons
NOND of the cerebellar GABAergic interneurons has been little investigated. In mouse,
the stellate, basket and Golgi cells are generated postnatally from the VZ [23] in a cortical area
adjacent to the white matter. In monkeys, the proliferative territory of these neurons is instead close to
the EGZ [120]. Migration and PCD of the stellate and basket cells during the first three postnatal weeks
was studied in glutamic acid decarboxylase 67 (GAD67)/green fluorescent protein (GFP) knock-in
mice where the GABAergic neurons are tagged by GFP [121]. The GFP-positive cells underwent
a progressive numerical reduction from P5 to P21 in the white matter, in parallel with an increase
in the number of the fluorescent neurons in the molecular layer until P15. After tracing the S-phase
cells with BrdU, dual-labeled BrdU/GFP positive neurons were found in the white matter during the
P2–P8 interval, in the IGL at P7, and in the molecular layer at P9 [121]. These results confirmed that the
proliferation of the mouse stellate and basket cells started in the white matter and that these neurons
then migrated in an outward direction to reach the molecular layer. Migration was then followed
by nuclear condensation, revealed by Hoechst 33258, and an apoptotic process between P16–P17,
as demonstrated after immunocytochemical staining for single strand DNA and cleaved caspase-3,
and by the TUNEL method [121]. It thus seems possible that apoptosis of the GABAergic interneurons
is secondary to the failure to properly connect synaptically with their target, but further observations
would be required to fully clarify this point.
3.3. Glia
As often appears to be the case, apoptosis was comparatively poorly investigated in glia with
respect to in neurons. A study on the P7 rat cerebellum reported that about 50% of the pyknotic
cells in the white matter contained fragmented DNA, i.e., they were TUNEL-positive, and were
immunoreactive for the astrocytic marker glial fibrillary acidic protein (GFAP) [41]. In another TUNEL
assay, this time on the fetal and neonatal human brain, the authors, based on the lack of positive nuclei
in the EGL, Purkinje cell layer and dentate nucleus, concluded that apoptosis mainly affected the glial
cells [55]. More recent studies have rather suggested that active caspase-3 might be important for the
differentiation of the Bergmann glia [122].
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4. Non-Apoptotic Role of Caspase-3 in Cerebellar Development
In the normal developing and mature brain, caspases have been implicated in the regulation
of a series of events that are functionally very relevant, such as selective axonal degeneration (axon
pruning) and synapse weakening and elimination [123–126]. In cerebellum, it has long ago been
suggested that caspase-3 might intervene directly in the proliferation and differentiation of the CGCs
within the EGL [79]. To our knowledge, however, this matter has not been investigated further. Notably,
when we recently analyzed the levels of activity of caspase-3 in cerebellar slices [78], we observed
that the protease displayed low levels of activity in a subset CGCs, that these neurons were resistant
to challenge with apoptosis inducers or oxidative stressors, and that it was possible to capture the
existence of spots of intense caspase-3 activity in their processes, at a developmental stage when
cortical synapses are formed in the cerebellum.
5. Future Perspectives
The study of postnatal cerebellar development offers unique opportunities to inspect NOND
in vivo, as the process affects very high numbers of cells in a quite restricted temporal frame.
This allows one to analyze the cellular and molecular mechanisms of regulation despite that apoptotic
cells are very rapidly cleared from tissue. There are two main streams that, according to our opinion,
should be pursued in future studies. First, it will be important to compare cerebellar development
in altricial and precocial animals, as the latter have been, for the most, neglected in current studies.
This will hopefully help to more deeply dissect the pathways governing NOND in relation to normal
development. Second, it will be important to better analyze the role of caspase-3 in cerebellar NOLND,
primarily taking into consideration the recent findings indicating that the protease may be also
an important regulator of synaptogenesis.
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Aif Apoptosis-inducing factor
Apaf1 Apoptotic peptidase activating factor 1
BCL-2 B-cell lymphoma 2
BDNF Brain-derived neurotrophic factor
CGC(s) Cerebellar granule cell(s)
CHL1 Close homolog of L1
CNS Central nervous system
CPP32 32-kDa putative cysteine protease
ECFP Enhanced cyan fluorescent protein
EGL External granular layer
EGZ External germinal zone
Fh Flathead
FRET Fluorescence resonance energy transfer
GAD67 Glutamic acid decarboxylase 67
GFP Green fluorescent protein
Hq Harlequin
IAP(s) Inhibitors of apoptosis protein(s)
IGL Internal granular layer
LFG Lifeguard
mGluR5 Metabotropic glutamate receptor 5
MLKL Mixed lineage kinase domain like pseudokinase
NMDA N-methyl-D-aspartate
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NOND Naturally occurring neuronal death
OKA Okadaic acid
p75NTR p75 neurotrophin receptor
PARP-1 Poly ADP-ribose polymerase-1
PCD Programmed cell death
PCNA Proliferating cell nuclear antigen
PN(s) Purkinje neuron(s)
proBDNF BDNF precursor molecule
RGZ Rostral germinal zone
RIPK1 Serine/threonine-protein kinase 1
RIPK3 Serine/threonine-protein kinase 3
RL Rhombic lip
TrkB Tropomyosin receptor kinase B
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end labeling
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